- Home
- MPAA vs CTNM Comparison
MPAA vs CTNM Comparison
Compare MPAA & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPAA
- CTNM
- Stock Information
- Founded
- MPAA 1968
- CTNM 2009
- Country
- MPAA United States
- CTNM United States
- Employees
- MPAA N/A
- CTNM N/A
- Industry
- MPAA Auto Parts:O.E.M.
- CTNM
- Sector
- MPAA Consumer Discretionary
- CTNM
- Exchange
- MPAA Nasdaq
- CTNM Nasdaq
- Market Cap
- MPAA 281.2M
- CTNM 248.7M
- IPO Year
- MPAA 1994
- CTNM 2024
- Fundamental
- Price
- MPAA $16.02
- CTNM $12.19
- Analyst Decision
- MPAA
- CTNM Strong Buy
- Analyst Count
- MPAA 0
- CTNM 5
- Target Price
- MPAA N/A
- CTNM $22.20
- AVG Volume (30 Days)
- MPAA 184.4K
- CTNM 171.0K
- Earning Date
- MPAA 11-11-2025
- CTNM 11-05-2025
- Dividend Yield
- MPAA N/A
- CTNM N/A
- EPS Growth
- MPAA N/A
- CTNM N/A
- EPS
- MPAA 0.08
- CTNM N/A
- Revenue
- MPAA $775,831,000.00
- CTNM N/A
- Revenue This Year
- MPAA $10.44
- CTNM N/A
- Revenue Next Year
- MPAA $4.88
- CTNM N/A
- P/E Ratio
- MPAA $195.39
- CTNM N/A
- Revenue Growth
- MPAA 6.59
- CTNM N/A
- 52 Week Low
- MPAA $5.16
- CTNM $3.35
- 52 Week High
- MPAA $17.72
- CTNM $20.24
- Technical
- Relative Strength Index (RSI)
- MPAA 54.36
- CTNM 59.62
- Support Level
- MPAA $14.71
- CTNM $11.56
- Resistance Level
- MPAA $15.75
- CTNM $12.80
- Average True Range (ATR)
- MPAA 0.71
- CTNM 0.85
- MACD
- MPAA -0.10
- CTNM -0.06
- Stochastic Oscillator
- MPAA 60.93
- CTNM 69.14
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.